NCT07694284进行中（未招募）不适用
A Clinical Trial to Evaluate the Effects of Super Lungs Liquid Drops on Respiratory Comfort, Airway Soothing, and Overall Well-Being
SuperBonsai Inc.1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2026年7月2日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 35
- 试验地点
- 1
- 主要终点
- Respiratory comfort
研究概览
简要总结
This is a single-group, open-label, fully decentralized (virtual) clinical trial evaluating the effects of Super Lungs Liquid Drops on respiratory comfort, airway soothing, and overall well-being in generally healthy adults aged 18-65 who experience bothersome respiratory symptoms. All 35 enrolled participants will receive the active study product and self-administer 2 mL of the drops daily (two full droppers of 1 mL each, once daily with the first meal of the day) for 12 weeks.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Adults aged 18-65 years.
- •Over the past two months, has experienced bothersome coughing on a weekly basis.
- •Anyone who has experienced issues with at least two of the following over the past four weeks: chest tightness or congestion; persistent throat irritation or itchiness; excess mucus or phlegm buildup.
- •Generally healthy, without any uncontrolled chronic disease.
- •Willing to maintain their current diet, sleep pattern, and activity levels for the duration of the trial.
- •Resides in the United States.
- •Has access to the internet and a device (smartphone, tablet, or computer) capable of completing online questionnaires.
- •Willing to follow the study protocol and complete all required assessments.
排除标准
- •Anyone with a known allergy or sensitivity to any of the study product ingredients.
- •Anyone with a known allergy to plants in the Asteraceae/Compositae family.
- •Women who are pregnant, breastfeeding, or planning to become pregnant during the study period.
- •Anyone currently taking immunosuppressant medications (e.g., cyclosporine, methotrexate, biologics such as adalimumab or infliximab).
- •Anyone with a diagnosed autoimmune disorder (e.g., lupus, rheumatoid arthritis, multiple sclerosis).
- •Anyone with uncontrolled hypertension or currently taking antihypertensive medications, diuretics, or corticosteroids.
- •Anyone currently taking anticoagulant or antiplatelet medications (e.g., warfarin, heparin, clopidogrel).
- •Anyone with a chronic health condition that could impact their participation in this study, such as cancer, mental health disorders, a history of serious illness in the last three months, a history of substance abuse, or planned surgery during the study period.
- •Anyone with a history of alcohol use disorder or currently in alcohol recovery.
- •Anyone currently participating in another research study or who plans to participate in another study during the study period. (
结局指标
主要结局
Respiratory comfort
时间窗: Baseline, Week 2, Week 4, Week 8, and Week 12
Change in self-reported respiratory comfort assessed by questionnaires.
Normal airway function
时间窗: Baseline, Week 2, Week 4, Week 8, and Week 12
Change in self-reported normal airway function assessed by questionnaires.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
2/3 期
Comparing Two Ayurvedic Treatments- Yashtimadhu churna and Pippali madhu yoga for Acid Reflux(Urdhwag Amlpitta)CTRI/2026/02/104489Dr Mrunal Chandrakant Nawkar88
招募中
不适用
Clinical Trial Evaluating the Safety and Efficacy of Tumor Thermosensitive Embolic Agent in Transcatheter Arterial Chemoembolization for Primary Liver CancerNCT07356531JIANGSU SHENMING Medical Technology CO., Ltd216
尚未招募
2 期
To compare Nidigdhikadi Yoga versus Shatyadi Churna in Bronchial AsthmaCTRI/2025/12/098830Institute for Ayurved Studies & Research Shri Krishna AYUSH University66
尚未招募
不适用
Efficacy of S.T.O.P®KIT in Retarding Axial Length Growth in Children With Low HyperopiaHyperopiaNCT07401511Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine180
招募中
2 期
A Study of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant TumorsNCT07448922Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.280